|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 846.4 DKK | -1.79% |
|
-7.66% | +9.64% |
| 02-27 | Certain B Shares of Coloplast A/S are subject to a Lock-Up Agreement Ending on 27-FEB-2024. | CI |
| 02-14 | COLOPLAST : Q1 24: Many more positives beyond the margin beat |  |
Contraline has appointed Dr. Yelena Tropsha to the role of chief technology officer. Dr. Tropsha brings to Contraline over 25 years of medical device experience, from front-end innovation to commercialization.
| 1st Jan change | Capi. | |
|---|---|---|
| +9.64% | 27.84B | |
| -29.83% | 3.04B | |
| -15.97% | 2.56B | |
| +18.11% | 2.33B | |
| +3.70% | 1.99B | |
| -9.47% | 1.87B | |
| -2.22% | 1.49B | |
| +2.19% | 1.27B | |
| +18.92% | 1.15B | |
| +3.72% | 1.12B |
COLOPLAST A/S 
